Skip to main content

Tagged (DIVA) polyantigenic vaccine against Bovine Viral Diarrhea virus (BVDv) based on virus-Like-Particles

Project description

A novel vaccine safeguards cattle health and productivity

Vaccination constitutes the most efficient strategy for protecting livestock against various diseases, minimising the use of antibiotics. Bovine viral diarrhoea (BVD) is an endemic disease of cattle caused by the BVD virus (BVDV). Currently, there are no eradication or control programmes in place that would obviate the need for vaccines. The EU-funded BoVLP-BVD project has developed a novel vaccine against BVDV based on a virus-like particle patented technology. Scientists will undertake the necessary activities for the commercial-scale manufacturing and in vivo safety and efficacy assessment of the vaccine. Given that BVDV significantly affects herd productivity and reproduction with major economic costs, the BoVLP-BVD vaccine will help prevent the disease.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Coordinator

AQUILON CYL SOCIEDAD LIMITADA
Net EU contribution
€ 1 554 729,75
Address
Lugar Facultad De Veterinaria S/n Campus Vegazana
24000 Leon
Spain

See on map

Region
Castilla y León León
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 1 554 729,75